Tower View Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.89M Sell
9,670
-542
-5% -$549K 4.57% 4
2025
Q4
$11M Buy
10,212
+2
+0% +$1.91K 5.43% 2
2025
Q3
$7.79M Buy
10,210
+112
+1% +$83.3K 4.03% 5
2025
Q2
$7.87M Buy
10,098
+42
+0.4% +$32.6K 4.08% 4
2025
Q1
$8.31M Sell
10,056
-59
-0.6% -$49.1K 4.84% 1
2024
Q4
$7.81M Buy
10,115
+65
+0.6% +$53.8K 4.13% 2
2024
Q3
$8.9M Sell
10,050
-28
-0.3% -$25.2K 4.87% 1
2024
Q2
$9.12M Sell
10,078
-22
-0.2% -$17.6K 5.24% 1
2024
Q1
$7.86M Sell
10,100
-1,693
-14% -$1.2M 4.6% 1
2023
Q4
$6.87M Sell
11,793
-386
-3% -$225K 4.26% 1
2023
Q3
$6.54M Sell
12,179
-1,903
-14% -$981K 4.59% 1
2023
Q2
$6.6M Sell
14,082
-1,306
-8% -$548K 4.48% 1
2023
Q1
$5.28M Sell
15,388
-83
-0.5% -$28K 3.55% 4
2022
Q4
$5.66M Sell
15,471
-777
-5% -$275K 3.93% 1
2022
Q3
$5.25M Buy
16,248
+71
+0.4% +$22.5K 4% 1
2022
Q2
$5.25M Sell
16,177
-379
-2% -$114K 3.85% 3
2022
Q1
$4.74M Buy
16,556
+238
+1% +$61.3K 2.55% 10
2021
Q4
$4.51M Buy
16,318
+180
+1% +$45.6K 2.3% 11
2021
Q3
$3.73M Sell
16,138
-2,474
-13% -$611K 2.07% 20
2021
Q2
$4.27M Sell
18,612
-1,638
-8% -$329K 2.16% 17
2021
Q1
$3.78M Sell
20,250
-3,722
-16% -$728K 2.07% 19
2020
Q4
$4.05M Sell
23,972
-1,978
-8% -$295K 2.3% 12
2020
Q3
$3.84M Buy
25,950
+622
+2% +$96.3K 2.5% 10
2020
Q2
$4.16M Sell
25,328
-248
-1% -$38.1K 3.04% 1
2020
Q1
$3.55M Buy
25,576
+443
+2% +$60.9K 3.2% 5
2019
Q4
$3.3M Buy
25,133
+327
+1% +$37.9K 2.5% 9
2019
Q3
$2.77M Buy
24,806
+260
+1% +$28.9K 2.29% 15
2019
Q2
$2.72M Buy
24,546
+486
+2% +$57.2K 2.32% 15
2019
Q1
$3.12M Buy
24,060
+23,903
+15,225% +$2.91M 2.77% 6
2018
Q4
$18K Hold
157
0.02% 103
2018
Q3
$17K Buy
157
+1
+0.6% +$100 0.01% 116
2018
Q2
$13K Buy
156
+1
+0.6% +$82 0.01% 115
2018
Q1
$12K Buy
155
+1
+0.6% +$81 0.01% 116
2017
Q4
$13K Buy
+154
New +$13.1K 0.01% 118

Other funds holding LLY

Tower View Wealth Management's LLY Position: Q1 2026 in Review

Tower View Wealth Management reduced its Eli Lilly (LLY) stake by 5.3% in Q1 2026, selling an estimated $549K and leaving 9,670 shares worth $8.89M. The position accounts for 4.57% of the portfolio, ranked #4.

Tower View Wealth Management first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $11M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tower View Wealth Management held 9,670 shares of Eli Lilly worth $8.89M as of Q1 2026.
  • Tower View Wealth Management sold 542 Eli Lilly shares in Q1 2026, an estimated $549K.
  • Eli Lilly made up 4.57% of Tower View Wealth Management's portfolio in Q1 2026, its #4 holding.
  • Tower View Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
  • Tower View Wealth Management's Eli Lilly position peaked at $11M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tower View Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.